SG11201706223VA - Biomarkers for pancreatic cancer - Google Patents
Biomarkers for pancreatic cancerInfo
- Publication number
- SG11201706223VA SG11201706223VA SG11201706223VA SG11201706223VA SG11201706223VA SG 11201706223V A SG11201706223V A SG 11201706223VA SG 11201706223V A SG11201706223V A SG 11201706223VA SG 11201706223V A SG11201706223V A SG 11201706223VA SG 11201706223V A SG11201706223V A SG 11201706223VA
- Authority
- SG
- Singapore
- Prior art keywords
- biomarkers
- pancreatic cancer
- pancreatic
- cancer
- Prior art date
Links
- 206010061902 Pancreatic neoplasm Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 title 1
- 201000002528 pancreatic cancer Diseases 0.000 title 1
- 208000008443 pancreatic carcinoma Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Hospice & Palliative Care (AREA)
- Analytical Chemistry (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1501930.0A GB201501930D0 (en) | 2015-02-05 | 2015-02-05 | Biomarkers for pancreatic cancer |
| PCT/GB2016/050277 WO2016124947A1 (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201706223VA true SG11201706223VA (en) | 2017-08-30 |
Family
ID=52746188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201706223VA SG11201706223VA (en) | 2015-02-05 | 2016-02-05 | Biomarkers for pancreatic cancer |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10782301B2 (enExample) |
| EP (2) | EP3254111A1 (enExample) |
| JP (1) | JP6786499B2 (enExample) |
| KR (1) | KR102569984B1 (enExample) |
| CN (1) | CN107533062B (enExample) |
| AU (1) | AU2016214140B2 (enExample) |
| BR (1) | BR112017016808A2 (enExample) |
| CA (1) | CA2974775C (enExample) |
| CL (1) | CL2017001972A1 (enExample) |
| GB (1) | GB201501930D0 (enExample) |
| HK (1) | HK1247276A1 (enExample) |
| IL (1) | IL253710B (enExample) |
| MX (1) | MX2017009998A (enExample) |
| SG (1) | SG11201706223VA (enExample) |
| WO (1) | WO2016124947A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10782301B2 (en) | 2015-02-05 | 2020-09-22 | Queen Mary University Of London | Biomarkers for pancreatic cancer |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3851856A3 (en) | 2007-03-27 | 2021-11-03 | Immunovia AB | Method, array and use thereof |
| GB201517028D0 (en) * | 2015-09-25 | 2015-11-11 | Univ London Queen Mary | Novel biomarkers for pancreatic cancer |
| CN107674884A (zh) * | 2017-09-05 | 2018-02-09 | 上海速创诊断产品有限公司 | 一种用于检测胰腺癌标记物reg1a的生物素化脂质体及其制备方法和应用 |
| TWI643869B (zh) * | 2017-12-14 | 2018-12-11 | 國立高雄大學 | Molecular extension printing material and preparation method thereof, magnetic molecular extension printing material and preparation method thereof |
| US20210052231A1 (en) * | 2017-12-14 | 2021-02-25 | Salcit Technologies Private Limited | Method and system for analyzing risk associated with respiratory sounds |
| KR102000387B1 (ko) * | 2018-02-13 | 2019-07-15 | 서울대학교산학협력단 | 췌관내유두상점액종양의 악성도를 감별할 수 있는 단백질 바이오마커 및 그 용도 |
| CN109358055A (zh) * | 2018-12-18 | 2019-02-19 | 沈阳理工大学 | 增敏测定空气中氨的混合指示剂试纸及其制备和检测方法 |
| CN111303281A (zh) * | 2019-05-14 | 2020-06-19 | 长春恒晓生物科技有限责任公司 | 制备胰石蛋白抗体及建立检测psp方法 |
| EP4045912A1 (en) * | 2019-10-18 | 2022-08-24 | Reccan Diagnostics AB | Apparatuses and methods for detection of pancreatic cancer |
| GB202010970D0 (en) * | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
| CN113248609B (zh) * | 2021-07-14 | 2021-09-10 | 深圳市盛波尔生命科学技术有限责任公司 | 针对再生胰岛衍生蛋白1α的抗体组合以及包含其的检测试剂盒 |
| CN115290732B (zh) * | 2022-07-14 | 2025-02-25 | 西北大学 | 一种检测胰蛋白酶的电化学生物传感器及其制备方法 |
| CN119724622B (zh) * | 2024-11-25 | 2025-12-12 | 中国人民解放军总医院第五医学中心 | 一种评价ptt对胰腺癌治疗效果的方法、系统及设备 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| GB9827228D0 (en) | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
| US7601826B2 (en) * | 2002-09-30 | 2009-10-13 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human pancreatic cancers |
| AU2003900747A0 (en) | 2003-02-18 | 2003-03-06 | Garvan Institute Of Medical Research | Diagnosis and treatment of pancreatic cancer |
| US20050095611A1 (en) | 2003-05-02 | 2005-05-05 | Chan Daniel W. | Identification of biomarkers for detecting pancreatic cancer |
| AU2004239418A1 (en) | 2003-05-15 | 2004-11-25 | Europroteome Ag | Biomarkers for the differential diagnosis of pancreatitis and pancreatic cancer |
| DE102004042822A1 (de) | 2004-08-31 | 2006-03-16 | Technische Universität Dresden | Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen |
| CA2595377A1 (en) | 2005-01-28 | 2006-08-03 | Children's Medical Center Corporation | Methods for diagnosis and prognosis of epithelial cancers |
| AU2006261671A1 (en) | 2005-06-27 | 2007-01-04 | John Wayne Cancer Institute | Molecular/genetic aberrations in surgical margins of resected pancreatic cancer represents neoplastic disease that correlates with disease outcome |
| WO2007035684A2 (en) | 2005-09-16 | 2007-03-29 | Primera Biosystems, Inc. | Method for quantitative detection of short rna molecules |
| WO2007081680A2 (en) | 2006-01-05 | 2007-07-19 | The Ohio State University Research Foundation | Microrna expression abnormalities in pancreatic endocrine and acinar tumors |
| WO2007098102A2 (en) | 2006-02-17 | 2007-08-30 | Children's Medical Center Corporation | Free ngal as a biomarker for cancer |
| US20070231822A1 (en) | 2006-02-28 | 2007-10-04 | Michael Mitas | Methods for the detection and treatment of cancer |
| EP2115138A2 (en) | 2006-09-19 | 2009-11-11 | Asuragen, Inc. | Micrornas differentially expressed in pancreatic diseases and uses thereof |
| US20080199455A1 (en) | 2006-10-03 | 2008-08-21 | Lobie Peter E | Conformation specific antibodies that bind trefoil factors and methods of treating cancers and proliferation disorders using same |
| US20100092476A1 (en) | 2006-11-17 | 2010-04-15 | Hanash Samir M | Pancreatic cancer biomarkers |
| EP2142659A4 (en) | 2007-04-30 | 2010-06-09 | Univ Ohio State Res Found | METHOD FOR THE DISTINCTION OF PANCREATIC CANCER OF NORMAL IMMERSION SPECTRUM FUNCTIONS AND CHRONIC IMMERSION IMAGING IGNITION |
| CA2723972A1 (en) | 2008-05-12 | 2009-11-19 | Genomic Health Inc. | Tests to predict responsiveness of cancer patients to chemotherapy treatment options |
| WO2009147530A2 (en) | 2008-06-06 | 2009-12-10 | Neuren Pharmaceuticals Ltd | Conformation specific antibodies that bind trefoil factors |
| JP2012100536A (ja) * | 2009-03-02 | 2012-05-31 | Genescience Co Ltd | 血液試料に含まれる単核球細胞を用いた癌関連遺伝子の発現解析による癌の遺伝子検査方法 |
| EP3075390A1 (en) * | 2010-01-19 | 2016-10-05 | Immunomedics Inc. | Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r) |
| EP2415877A3 (en) * | 2010-02-17 | 2012-02-15 | Deutsches Krebsforschungszentrum | Means and methods for diagnosing pancreatic cancer |
| WO2011137288A2 (en) | 2010-04-30 | 2011-11-03 | The Ohio State University | Mirna networks in cancers and leukemias and uses thereof |
| WO2012100339A1 (en) * | 2011-01-27 | 2012-08-02 | University Health Network | Methods and compositions for the detection of pancreatic cancer |
| US9644241B2 (en) | 2011-09-13 | 2017-05-09 | Interpace Diagnostics, Llc | Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease |
| EP2758079A4 (en) | 2011-09-21 | 2015-05-13 | Univ North Carolina | PROCESS WITH BIOMARKERS FOR LIVER DISEASE |
| DE102012204366B4 (de) | 2011-12-16 | 2017-07-27 | Siemens Aktiengesellschaft | Verfahren und Kit zur Identifizierung und Quantifizierung von einer einzelsträngigen Ziel-Nukleinsäure |
| US20150018235A1 (en) | 2012-01-13 | 2015-01-15 | Oncocyte Corporation | Methods and Compositions for the Treatment and Diagnosis of Pancreatic Cancer |
| US20150011414A1 (en) | 2012-01-16 | 2015-01-08 | Herlev Hospital | Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples |
| US20130216545A1 (en) | 2012-02-19 | 2013-08-22 | Claresa Levetan | Early Diagnosis and Novel Treatment of Cancer |
| WO2013152989A2 (en) * | 2012-04-10 | 2013-10-17 | Eth Zurich | Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer |
| US20130317083A1 (en) | 2012-05-04 | 2013-11-28 | Thomas Jefferson University | Non-coding transcripts for determination of cellular states |
| WO2014062856A1 (en) | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
| US20140271621A1 (en) * | 2013-03-14 | 2014-09-18 | Abbott Laboratories | Methods of prognosis and diagnosis of pancreatic cancer |
| US20150018230A1 (en) | 2013-06-11 | 2015-01-15 | Indiana University Research And Technology Corp. | PLASMA miRNA SIGNATURE FOR THE ACCURATE DIAGNOSIS OF PANCREATIC DUCTAL ADENOCARCINOMA |
| GB201501930D0 (en) | 2015-02-05 | 2015-03-25 | Univ London Queen Mary | Biomarkers for pancreatic cancer |
| GB201517028D0 (en) | 2015-09-25 | 2015-11-11 | Univ London Queen Mary | Novel biomarkers for pancreatic cancer |
-
2015
- 2015-02-05 GB GBGB1501930.0A patent/GB201501930D0/en not_active Ceased
-
2016
- 2016-02-05 WO PCT/GB2016/050277 patent/WO2016124947A1/en not_active Ceased
- 2016-02-05 HK HK18106404.7A patent/HK1247276A1/zh unknown
- 2016-02-05 EP EP16703840.5A patent/EP3254111A1/en active Pending
- 2016-02-05 CA CA2974775A patent/CA2974775C/en active Active
- 2016-02-05 BR BR112017016808A patent/BR112017016808A2/pt not_active Application Discontinuation
- 2016-02-05 EP EP24188089.7A patent/EP4458849A3/en active Pending
- 2016-02-05 US US15/548,240 patent/US10782301B2/en active Active
- 2016-02-05 KR KR1020177024461A patent/KR102569984B1/ko active Active
- 2016-02-05 JP JP2017541693A patent/JP6786499B2/ja active Active
- 2016-02-05 MX MX2017009998A patent/MX2017009998A/es unknown
- 2016-02-05 AU AU2016214140A patent/AU2016214140B2/en active Active
- 2016-02-05 CN CN201680018784.8A patent/CN107533062B/zh active Active
- 2016-02-05 SG SG11201706223VA patent/SG11201706223VA/en unknown
-
2017
- 2017-07-28 IL IL253710A patent/IL253710B/en active IP Right Grant
- 2017-08-02 CL CL2017001972A patent/CL2017001972A1/es unknown
-
2020
- 2020-08-26 US US17/003,139 patent/US11977077B2/en active Active
-
2024
- 2024-04-02 US US18/624,620 patent/US20250251399A1/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10782301B2 (en) | 2015-02-05 | 2020-09-22 | Queen Mary University Of London | Biomarkers for pancreatic cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| IL253710A0 (en) | 2017-09-28 |
| EP4458849A3 (en) | 2024-12-04 |
| US20220042998A1 (en) | 2022-02-10 |
| CN107533062B (zh) | 2021-03-23 |
| BR112017016808A2 (pt) | 2018-04-03 |
| CA2974775A1 (en) | 2016-08-11 |
| JP6786499B2 (ja) | 2020-11-18 |
| US20250251399A1 (en) | 2025-08-07 |
| US11977077B2 (en) | 2024-05-07 |
| AU2016214140B2 (en) | 2021-11-04 |
| CL2017001972A1 (es) | 2018-03-23 |
| CA2974775C (en) | 2023-11-07 |
| JP2018504609A (ja) | 2018-02-15 |
| HK1247276A1 (zh) | 2018-09-21 |
| KR20170129118A (ko) | 2017-11-24 |
| IL253710B (en) | 2020-08-31 |
| MX2017009998A (es) | 2018-02-01 |
| WO2016124947A1 (en) | 2016-08-11 |
| US20190204323A1 (en) | 2019-07-04 |
| CN107533062A (zh) | 2018-01-02 |
| EP3254111A1 (en) | 2017-12-13 |
| AU2016214140A1 (en) | 2017-08-17 |
| KR102569984B1 (ko) | 2023-08-22 |
| EP4458849A2 (en) | 2024-11-06 |
| US10782301B2 (en) | 2020-09-22 |
| GB201501930D0 (en) | 2015-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201706223VA (en) | Biomarkers for pancreatic cancer | |
| GB2566681B (en) | Biomarker | |
| SG10202110526WA (en) | Biomarkers for cancer therapeutics | |
| GB201614455D0 (en) | Biomarkers | |
| GB201500584D0 (en) | Cancer biomarkers | |
| PL3593139T3 (pl) | Biomarkery nowotworowe | |
| SG10202007262PA (en) | Copanlisib biomarkers | |
| SG10202007322PA (en) | Copanlisib biomarkers | |
| ZA201705532B (en) | Biomarkers for preeclampsia | |
| IL254149A0 (en) | Innovative treatments for cancer | |
| HUE057564T2 (hu) | Méhnyakrák biomarkerei | |
| ZA202001821B (en) | Biomarker | |
| GB201710858D0 (en) | Biomarker | |
| GB201500729D0 (en) | Novel Biomarkers | |
| GB201517028D0 (en) | Novel biomarkers for pancreatic cancer | |
| GB201703123D0 (en) | Biomarkers | |
| IL259661A (en) | Biomarkers for cancer treatment with epilimod | |
| GB201512133D0 (en) | Biomarkers | |
| GB201506666D0 (en) | Biomarkers for prostate cancer | |
| GB201703641D0 (en) | Cancer biomarkers | |
| GB201720776D0 (en) | Biomarkers | |
| GB201519704D0 (en) | Biomarkers | |
| GB201513683D0 (en) | Biomarkers | |
| GB201521446D0 (en) | Biomarker | |
| GB201707113D0 (en) | Biomarker |